Hepatitis C Committee

Chair: Dr. P. Kishore, MD, MPH, CMA

(Boston NAMA)

Committee Members

Paul Bowman, CMA 

Cheri Jarvis, CMA 


The HCV Committee was created to empower methadone patients through education and advocacy and to provide support for those that do test positive for Hepatitis C.


What Is Hepatitis C?

  • Hepatitis is an inflammation of the liver. Although in many people the diseased liver is able to repair itself and regain function, it may progress to scarring of the liver and chronic liver disease. Hepatitis can have numerous causes. A common cause is infection with one of the several types of viruses (e.g., hepatitis A, B, or C viruses).
  • Hepatitis C virus (HCV) infection occurs when blood, or other body fluids from an infected person enters the body of an uninfected person. In 2000, about 30,000 new infections occurred. Most of these infections occurred among young adults 20-39 years old. Injection drug use and blood transfusion prior to 1992 are major risk factor for HCV infection. About 3.9 million American have been infected with HCV and 2.7 million have chronic infection. In 2000, about 30,000 new infections occurred. Most of these infections occurred among young adults 20-39 years old.
  • HCV infection is becoming a leading cause of cirrhosis. In addition to genetic factors in the infected person three independent factors are associated with an increased rate of disease progression. These factors include daily alcohol consumption, age at infection of more than 40 years, and male gender. These factors have a greater influence on progression to cirrhosis in HCV infection than the virus itself.

What Should You Do If You Have Hepatitis C?

  • There are several actions all people who have chronic viral hepatitis C should take as general measures. Most important of all is to not drink alcoholic beverages, and if necessary, get into treatment, because alcohol makes liver disease worse. Injection drug users should stop injecting drugs and get into and stay in substance abuse treatment. All individuals with chronic liver disease should be immunized against hepatitis A. Individuals with chronic HCV who are at risk also should be immunized against hepatitis B.

Surviving Hep C Group

This group is a support group with emphasis on Hepatitis C. Everyone is welcome to share their experience’s and stories in this group no matter what your status might be. Everyone is encouraged to share information and educational topics. Hepatitis C can be survived, but we have to empower ourselves with knowlege and be our own treatment advocates.

Come on and join NAMA’s hepatitis group and talk with others who have HCV.

http://groups.yahoo.com/group/SurvivingHepC/

Contact List Manager Cheri Jarvis, CMA

[email protected]


Important Documents


Info Facts


Info Facts are prepared by the HCV Committee and under the direction of Dr. Kishore.

Publications


Similar Posts

  • NAMA’s Comments to State Medical Board Model Policy Guidelines

    Admin 10/22/2021

    National Alliance of Methadone Advocates 435 Second Avenue New York, NY 10010 Phone: (212) 595-6262 Review Guidelines for the Federation of State Medical Boards Model Policy Guidelines for Opioid Addiction Treatment in the Medical Office Section I Preamble Paragraph 2 The second sentence should also include the fact that Medical Maintenance has been demonstrated to…

  • Expectations

    Admin 09/04/2021

    Every patient, in fact every member of the methadone community, has a right to expect that someone who represents themselves as a methadone advocate be knowledgeable in all aspects of methadone treatment. NAMA has created the Methadone Advocate Training and Methadone Advocate Certification for a whole host of reasons. Most of which we will discuss…

  • Stop Methadone Ignorance

    Admin 05/22/2021

    STOP METHADONE IGNORANCE It is not uncommon for individuals with a long history of illicit opiate use to remain in methadone treatment as a long term patient. Many often say that without methadone treatment they would probably be dead. Other forms of treatment were not effective and they had come to believe that they would…

  • Drug Court Fact Sheet

    Admin 01/29/2022

    Methadone Maintenance and Other Pharmacotherapeutic Interventions in the Treatment of Opioid Dependence. Overview Drug Courts are being confronted with increasing numbers of opiate dependent offenders. This Fact Sheet is intended to dispel misperceptions and educate practitioners about the efficacy of medication assisted treatment. Opioid dependence is a devastating reality and a treatable disease. According to…

  • Late Breaking News

    Admin 09/01/2021

    Best Practices: Treatment of Opiate Dependence Conference Update   Physician Training for Use of Buprenorphine   The conference planning committee working with the Center for Substance Abuse Treatment and the American Academy of Addictions Psychiatry will be offering the following 8-hour physician workshop during the Best Practices: Treatment of Opiate Dependence Conference, scheduled for March…

  • Grievence Report Form Webpage

    Admin 04/04/2021

    Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment (CSAT) Telephone (240) 276-2717 1Choke Cherry Road, Room 2-1065 Facsimile (240) 276-1630 Rockville, Maryland 20857 E-mail: [email protected] Division of Pharmacologic Therapies DPT C. Todd Rosendale, MA Public Health Advisor ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ FACSIMILE AInformation Memorandum@   This facsimile is intended only for the addressee…